Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
the NRG-ErbB4 signaling pathway can potentially influence many functional systems throughout the brain of primates, and suggest that major sites of action are areas of the "corticolimbic" network
Widespread expression of ErbB4 receptor mRNAs was found throughout the telencephalon of juvenile and adult monkeys with in situ hybridization, with higher levels in grey matter compared to white matter.
ErbB (show EGFR ELISA Kits) signaling control both convergent extension and head mesoderm migration during gastrulation.
we show that the antifibrotic effect of neuregulin-1 (show NRG1 ELISA Kits) is at least partially mediated through anti-inflammatory activity, linked to receptor tyrosine-protein kinase erbB-4 activation in macrophages
These results suggest that the neuropsin (show KLK8 ELISA Kits)-NRG1 (show NRG1 ELISA Kits) signaling system has a role in pathological processes underlying temporal lobe epilepsy by regulating the activity of parvalbumin (show PVALB ELISA Kits)-expressing interneurons, and that neuropsin (show KLK8 ELISA Kits) regulates E/I balance and gamma oscillations through NRG1 (show NRG1 ELISA Kits)-ErbB4 signaling toward parvalbumin (show PVALB ELISA Kits)-expressing interneurons.
findings reveal molecular, cellular, and circuit mechanisms of NRG1 (show NRG1 ELISA Kits)/ErbB4 in regulating the initiation of critical period visual cortical plasticity.
To our knowledge, this is the first evidence that ErbB4 signaling in the MSNs is involved in the pathology of schizophrenia.
opposing signals generated by different ErbB (show EGFR ELISA Kits) dimer combinations function in the same cardiac cushion mesenchymal cells for proper cardiac valve formation.
Study revealed that bed nucleus of the stria terminalis NRG1 (show NRG1 ELISA Kits)-ErbB4 signaling is involved in regulating anxiety, and that blocking this pathway produced anxiety-like behavior.
Parallel microarray profiling identifies Erbb4 as a marker of cyst growth in autosomal dominant polycystic kidney disease and as a prognostic marker for disease progression.
a suppressor of miR (show MLXIP ELISA Kits)-146a, suggesting an autocrine loop. Inhibition of ErbB4/EGFR (show EGFR ELISA Kits) with erlotinib co-treatment of podocytes suppressed this signaling. Findings suggest a novel role for miR (show MLXIP ELISA Kits)-146a in protecting against diabetic glomerulopathy and podocyte injury.
the disruption of NRG1 (show NRG1 ELISA Kits)-ErbB4 signaling in the parvalbumin (show PVALB ELISA Kits) interneurons mediated by neuroinflammation might lead to abnormal gamma oscillations and thus contribute to cognitive impairment in a mouse model of SAE
the cleavage of ErbB4 by calpain contributes to a neuronal cell death cascade during brain ischemia.
High ERBB4 expression is associated with Merkel cell carcinoma
High ERBB4 expression is associated with colon cancer metastasis.
ERBB4 mutation is associated with Metaplastic Breast Cancer.
Results show higher expression levels of ErbB4 and KITENIN (show Vangl1 ELISA Kits) in stage IV colorectal cancer tissues resulting in elevated phosphorylated level of ERBB2 (show ERBB2 ELISA Kits).
We directly link TDP-43 (show TARDBP ELISA Kits) loss of function toxicity to two genes with rare amyotrophic lateral sclerosis and frontotemporal lobar degeneration-causing mutations, CHMP2B (show CHMP2B ELISA Kits) and ErbB4
Differential expression patterns of EGF (show EGF ELISA Kits), EGFR (show EGFR ELISA Kits), and ERBB4 are essential in epithelial restitution and remodeling in nasal epithelium.
There were significant differences in human epidermal growth factor receptor (show EGFR ELISA Kits) 2 and human epidermal growth factor receptor (show EGFR ELISA Kits) 3 serum levels between the patients with tissue human epidermal growth factor receptor (show EGFR ELISA Kits) 2-positive and tissue human epidermal growth factor receptor (show EGFR ELISA Kits) 2-negative ( p = 0.0026, p = 0.000011) tumors, but not in the serum levels of human epidermal growth factor receptor (show EGFR ELISA Kits) 4 ( p = 0.054).
the HER4 G1109C mutation is an activating oncogenic mutation with a transformational ability and that afatinib was effective against an HER4 G1109C-mutated HNSCC cell line by inhibiting the HER4 signal, both in vitro and in vivo.
identified a novel Her4-induced posttranslational modification on MDMX (show MDM4 ELISA Kits)
This gene is a member of the Tyr protein kinase family and the epidermal growth factor receptor subfamily. It encodes a single-pass type I membrane protein with multiple cysteine rich domains, a transmembrane domain, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. Mutations in this gene have been associated with cancer. Alternatively spliced variants which encode different protein isoforms have been described\; however, not all variants have been fully characterized.
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)
, receptor tyrosine-protein kinase erbB-4
, v-erb-a erythroblastic leukemia viral oncogene homolog 4
, receptor tyrosine-protein kinase erbB-4-like
, receptor tyrosine kinase ErbB4
, receptor tyrosine-protein kinase ErbB-4
, ovarian receptor tyrosine kinase erbB4 precusor
, receptor tyrosine kinase
, avian erythroblastosis oncogene B 4
, proto-oncogene-like protein c-ErbB-4
, avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 4
, tyrosine kinase-type cell surface receptor HER4